NDC Package 51991-895-33 Entecavir

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51991-895-33
Package Description:
30 TABLET in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Entecavir
Non-Proprietary Name:
Entecavir
Substance Name:
Entecavir
Usage Information:
See also Warning section. Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the hepatitis B virus. Long-term infection can cause liver damage, rarely liver cancer, and liver failure. Entecavir helps to decrease the amount of hepatitis B virus in your body. It is unknown if this medication lowers your chance of getting liver cancer or liver damage. Entecavir is an antiviral that belongs to a class of drugs known as hepatitis B virus nucleoside reverse transcriptase inhibitors. Entecavir is not a cure for hepatitis B. It does not prevent the spread of the virus to others through sexual contact or blood/body fluid contamination (such as sharing used needles).
11-Digit NDC Billing Format:
51991089533
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 485434 - entecavir 0.5 MG Oral Tablet
  • RxCUI: 485436 - entecavir 1 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Breckenridge Pharmaceutical, Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA208721
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-16-2018
    End Marketing Date:
    01-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51991-895-33?

    The NDC Packaged Code 51991-895-33 is assigned to a package of 30 tablet in 1 bottle, plastic of Entecavir, a human prescription drug labeled by Breckenridge Pharmaceutical, Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 51991-895 included in the NDC Directory?

    Yes, Entecavir with product code 51991-895 is active and included in the NDC Directory. The product was first marketed by Breckenridge Pharmaceutical, Inc. on March 16, 2018.

    What is the NDC billing unit for package 51991-895-33?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 51991-895-33?

    The 11-digit format is 51991089533. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-251991-895-335-4-251991-0895-33